Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v3-FR
Language French French
Date Updated 2024-02-06 2020-09-24
Drug Identification Number 00701785 00701785
Brand name OPTIMYXIN OPTIMYXIN
Common or Proper name Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution
Company Name EURO-PHARM INTERNATIONAL CANADA INC EURO-PHARM INTERNATIONAL CANADA INC
Ingredients GRAMICIDIN POLYMYXIN B GRAMICIDIN POLYMYXIN B
Strength(s) 0.025MG 10000UNIT 0.025MG 10000UNIT
Dosage form(s) DROPS DROPS
Route of administration OPHTHALMIC OTIC OPHTHALMIC OTIC OPHTHALMIC OTIC OPHTHALMIC OTIC
Packaging size 10 mL 10 mL
ATC code S03AA S03AA
ATC description ANTIINFECTIVES ANTIINFECTIVES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-11-01 2020-11-01
Actual start date
Estimated end date 2025-07-01 2021-11-01
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Reason for shortage: Transfer of manufacturing site. The estimated end date depends on approval timelines for the manufacturing site transfer. Reason for shortage: Transfer of manufacturing site. The estimated end date depends on approval timelines for the manufacturing site transfer.
Health Canada comments